Treatment recommendations for cystic fibrosis-related diabetes: Too little, too late?

Thorax

Volumn 66, Issue 7, 2011, Pages 555-556

  Nathan, Brandon ^a   Moran, Antoinette ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

BODY WEIGHT; CHRONIC INFLAMMATION; CYSTIC FIBROSIS; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DISEASE ASSOCIATION; EDITORIAL; GLUCOSE BLOOD LEVEL; GOLD STANDARD; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEFICIENCY; INSULIN TREATMENT; LUNG FUNCTION; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; OXYGEN SATURATION; PRIORITY JOURNAL; SLEEP APNEA SYNDROME;

EID: 79959316210     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2010.157883     Document Type: Editorial

References (9)

1. Schwarzenberg SJ, Thomas W, Olsen TW, et al. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care 2007;30:1056-61. (Pubitemid 46684624)
2. Moran A, Becker D, Casella SJ, et al; CFRD Consensus Conference Committee. Epidemiology, pathophysiology and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care 2010;33:2677-83.
3. Moran A, Dunitz J, Nathan B, et al. Cystic fibrosis related diabetes: current trends in prevalence, incidence and mortality. Diabetes Care 2009;32:1626-31.
4. Moran A, Pekow P, Grover P, et al; Cystic Fibrosis Related Diabetes Therapy Study Group. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. Diabetes Care 2009;32:1783-8.
5. Milla CE, Warwick WJ, Moran AM. Trends in pulmonary function in cystic fibrosis patients correlate with the results of oral glucose tolerance test at baseline. Am J Respir Crit Care Med 2001;162:891-5.
6. Brennan AL, Gyi KM, Wood DM, et al. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros 2007;6:101-9. (Pubitemid 46394299)
7. Suratwala D, Chan J, Kelly A, et al. Nocturnal saturation and glucose tolerance in children with cystic fibrosis. Thorax 2011;66:574-8.
8. Ulrich M, Worlitzsch D, Viglio S, et al. Alveolar inflammation in cystic fibrosis. J Cyst Fibros 2010;9:217-27.
9. Moran A, Brunzell C, Cohen RC, et al; CFRD Guidelines Committee. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement for the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010;33:2697-708.